Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eric Davis

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Blood|December 16, 2004
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cellsLiza Ho, R Eric Davis, Béatrice Conne, et al.
Blood|March 13, 2012
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell linesManuela Lemoine, Enrico Derenzini, Daniela Buglio, et al.
Leukemia Research|May 15, 2013
XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cellsBing Z Carter, Duncan H Mak, Zhiqiang Wang, et al.
Assay and Drug Development Technologies|March 16, 2007
A cell-based assay for IkappaBalpha stabilization using a two-color dual luciferase-based sensorR Eric Davis, Ya-Qin Zhang, Noel Southall, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Journal of Natural Products|December 20, 2008
Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosaTamara L Meragelman, Dominic A Scudiero, R Eric Davis, et al.
Immunological Reviews|April 21, 2006
A library of gene expression signatures to illuminate normal and pathological lymphoid biologyArthur L Shaffer, George Wright, Liming Yang, et al.
Experimental Hematology & Oncology|November 2, 2024
Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphomaKristyna Kupcova, Jana Senavova, Filip Jura, et al.
Carcinogenesis|March 16, 2002
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinomaAtsuko Shibata, Julie Parsonnet, Teri A Longacre, et al.
Haematologica|October 16, 2016
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugsRohit Mathur, Lalit Sehgal, Ondrej Havranek, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Blood|December 16, 2004
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cellsLiza Ho, R Eric Davis, Béatrice Conne, et al.
Blood|March 13, 2012
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell linesManuela Lemoine, Enrico Derenzini, Daniela Buglio, et al.
Leukemia Research|May 15, 2013
XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cellsBing Z Carter, Duncan H Mak, Zhiqiang Wang, et al.
Assay and Drug Development Technologies|March 16, 2007
A cell-based assay for IkappaBalpha stabilization using a two-color dual luciferase-based sensorR Eric Davis, Ya-Qin Zhang, Noel Southall, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Journal of Natural Products|December 20, 2008
Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosaTamara L Meragelman, Dominic A Scudiero, R Eric Davis, et al.
Immunological Reviews|April 21, 2006
A library of gene expression signatures to illuminate normal and pathological lymphoid biologyArthur L Shaffer, George Wright, Liming Yang, et al.
Experimental Hematology & Oncology|November 2, 2024
Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphomaKristyna Kupcova, Jana Senavova, Filip Jura, et al.
Carcinogenesis|March 16, 2002
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinomaAtsuko Shibata, Julie Parsonnet, Teri A Longacre, et al.
Haematologica|October 16, 2016
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugsRohit Mathur, Lalit Sehgal, Ondrej Havranek, et al.
Pageof 9